Personen Rick Greupink

Profiel

dr. Rick Greupink

contact

Over Rick Greupink

Rick Greupink's work aims to better understand the pharmacological mechanisms that determine drug disposition and toxicity, in order to improve drug safety and personalized pharmacotherapy. lees meer

Sluiten

Over Rick Greupink

Rick Greupink obtained an MSc in Pharmaceutical Sciences and completed his training as a pharmacist (PharmD) at the University of Groningen, where he also earned his PhD in Pharmacokinetics and Drug Delivery. He further specialised as a pharmacologist through postdoctoral fellowships in both clinical and pre-clinical settings, in pharmaceutical industry and academia.

Rick is an Associate Professor (universitair hoofddocent) and member of staff at the Department of Pharmacy, Pharmacology and Toxicology, as well as a member of Radboudumc’s Therapy Accelerator for Rare Diseases. At Radboud university medical center and Radboud University, he lectures in pharmacology and pharmacotherapy and plays an active role in education and curriculum development. Within the Biomedical Sciences Master’s programme at Radboud university medical center, he coordinates the specialisation Cell, Drug & Gene Therapy Development, which trains students in the full spectrum of therapy development.

His research focuses on the in vitro–to–in vivo extrapolation (IVIVE) of drug disposition and effects, by combining in vitro molecular pharmacology studies in human tissues and cells with in silico modelling. Current projects centre on the placental disposition and molecular effects of pharmaceuticals, with a focus on maternal, fetal and perinatal pharmacokinetics, drug safety and reproductive toxicology, and also include therapy development for vulnerable and rare disease populations.


Functie(s)

  • associate professor AFT

Nevenfuncties

  • Specialization coordinator, Master Biomedical Sciences: Development of Cell, Drug and Gene Therapies
  • Member of the Education Committee of the Dutch Pharmacological Society
  • Expert network member European Medicines Evaluation Board
lees meer

Sluiten

Nevenfuncties

  • Specialization coordinator, Master Biomedical Sciences: Development of Cell, Drug and Gene Therapies
  • Member of the Education Committee of the Dutch Pharmacological Society
  • Expert network member European Medicines Evaluation Board
  • Course Coordinator MOL53 (FNWI): Pharmacochemistry
  • Course Coordinator Master course BMS63 - Biodynamic and Toxicokinetic Modeling (graduate program biomedical sciences, drug safety and toxicology specialization)
  • Vice Coordinator of the elective Master course BMS92 - Organ Toxicology in Drug Safety (graduate program biomedical sciences)
  • Course Coordinator Master course BMS94 - Drug Development for Rare Diseases (graduate program biomedical sciences)
  • Secretary General & Treasurer of the Dutch Pharmacological Society (2019-2023)
  • Member of the Program Committee for Biomedical Sciences (Opleidingscommissie-BMW Radboudumc, 2017-2023)
  • Member of project monitoring board for Dutch government-funded project (ZonMw) on improvement of knowledge and knowledge infrastructure regarding drug use in pregnancy. (2013-2015)

Social media


Researchfunctie

  • associate professor